BBGBloomberg·2hBusiness
score+0.60
SpaceX Joins Nasdaq 100; Crinetics Pharmaceuticals Soars on Buyout | Stock Movers
Original
SpaceX Joins Nasdaq 100; Crinetics Pharmaceuticals Soars on Buyout | Stock Movers
“Mixed market movements described with celebratory language for acquisitions and index inclusion, despite SpaceX's stock decline.”